我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

舒张性心力衰竭与收缩性心力衰竭临床特征的比较

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2014年第4期
页码:
440-442,445
栏目:
临床研究
出版日期:
2014-04-25

文章信息/Info

Title:
Clinical characteristics and cardiac function evaluation in patients with diastolic heart failure and systolic heart failure
作者:
张 环; 李 涛
(西安市中心医院心内科，陕西 西安 710003)
Author(s):
ZHANG Huan;  LI Tao
(Department of Cardiology, Xi’an Central Hospital, Xi’an 710003, Shaanxi, China)
关键词:
心力衰竭; 舒张性; 心力衰竭; 收缩性; 脑钠尿肽; C反应蛋白
Keywords:
diastolic heart failure;  systolic heart failure;  brain natriuretic peptide;  C-reactive protein
分类号:
R541.61
DOI:
-
文献标识码:
A
摘要:
目的:探讨舒张性心力衰竭和收缩性心力衰竭患者临床特征的差异。方法： 选择心力衰竭患者253例，其中舒张性心力衰竭118例，收缩性心力衰竭135例。登记患者的临床资料，分析各组患者临床特征的差异。所有患者均检测N末端脑钠尿肽前体（NT-proBNP）及高敏C反应蛋白（hs-CRP）。结果： 舒张性心力衰竭和收缩性心力衰竭均以老年患者居多，前者以女性多见（56.8%），并发高血压病（81.4%）及心房颤动（26.3%）均高于于后者（前项P<0.01，后项P<0.05），并发冠心病（45.8%）少于后者（P<0.01）；两组NT-proBNP及hs-CRP均随着NYHA心功能分级增加而显著升高（P<0.01），舒张性心力衰竭组NT-proBNP低于收缩性心力衰竭组（P<0.01），但hs-CRP两组间差异无统计学意义。结论： 与收缩性心力衰竭相比，舒张性心力衰竭于老年女性更多见，高血压病患病率及心房颤动发生率较高，NT-proBNP水平较低。
Abstract:
AIM:To explore the clinical characteristics and cardiac function evaluation in patients with diastolic heart failure (DHF) and systolic heart failure (SHF). METHODS: A total of 253 patients with heart failure were selected including 118 DHF cases and 135 SHF cases, and 50 cases confirmed without organic heart disease served as control. Clinical data of patients were recorded and the differences of clinical characteristics between groups were analyzed. NT-proBNP and hs-CRP were detected in all patients. RESULTS: Both DHF and SHF were more common in elderly patients, but DHF was more common in females (56.8%). There were more patients with hypertension (81.4%) or atrial fibrillation (26.3%) in DHF group than in SHF group (P<0.01; P<0.05, respectively) and patients accompanied with CHD (45.8%) in DHF were less than those in SHF (P<0.01). Compared with those in the control group, NT-proBNP and hs-CRP in both DHF group and SHF group were significantly higher (P<0.01), but NT-proBNP in DHF group was lower than that in the SHF group (P<0.01). No significant difference was found in Hs-CRP between groups. CONCLUSION: DHF is more common in elderly females, which is often accompanied by hypertension or atrial fibrillation. NT-proBNP and hs-CRP can be used as indicators of the evaluation of heart failure both in DHF and in SHF.

参考文献/References

[1]中华医学会心血管病学分会.中国慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095.
[2]Hogg K,Swedberg K,McMurray J.Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics,and prognosis[J].Am Coll Cardiol,2004,43(3):317-327.
[3]Owan TE,Hodge DO,Herges RM,et al.Trends in prevalence and outcome of heart failure with preserved ejection fraction[J].N Engl J Med,2006,355(3):251-259.
[4]Lee DS,Gona P,Vasan RS,et al.Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction:insights from the framingham heart study of the national heart,lung,and blood institute[J].Circulation,2009,119(24):3070-3077.
[5]Parissis JT,Ikonomidis I,Rafouli-Stergiou P,et al.Clinical characteristics and predictors of in-hospital mortality in acute heart failure with preserved left ventricular ejection fraction[J].Am J Cardiol,2011,107(1):79-84.
[6]Bursi F,Weston SA,Redfield MM,et al.Systolic and diastolic heart failure in the community[J].JAMA,2006,296(18):2209-2216.
[7]Olsson LG,Swedberg K,Ducharme A,et al.Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction:results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program[J].J Am Coll Cardiol,2006,47(10):1997-2004.
[8]Caldwell JC,Mamas MA.Heart failure, diastolic dysfunction and atrial fibrillation; mechanistic insight of a complex inter-relationship[J].Heart Fail Rev,2012,17(1):27-33.
[9]Heymans S,Hirsch E,Anker SD,et al.Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology［J］. Eur J Heart Fail, 2009, 11(2):119-129.
[10]Araújo JP, Louren?o P,Azevedo A,et al.Prognostic value of high-sensitivity C-reactive protein in heart failure:a systematic review[J].J Card Fail,2009,15(3):256-266.

备注/Memo

备注/Memo:
收稿日期：2013-12-10.作者简介：张环，副主任医师，硕士 Email：doczhanghuan@163.com
更新日期/Last Update: 2014-05-06